Arvinas, Inc. (ARVN)
7.46
+0.05
(+0.67%)
USD |
NASDAQ |
Oct 05, 16:00
7.46
0.00 (0.00%)
Pre-Market: 08:19
Arvinas Market Cap : 487.14M for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 487.14M |
| October 02, 2026 | 483.87M |
| October 01, 2026 | 485.18M |
| September 30, 2026 | 505.10M |
| September 29, 2026 | 489.75M |
| September 28, 2026 | 490.40M |
| September 25, 2026 | 495.63M |
| September 24, 2026 | 508.69M |
| September 23, 2026 | 511.30M |
| September 22, 2026 | 555.70M |
| September 21, 2026 | 541.99M |
| September 18, 2026 | 541.34M |
| September 17, 2026 | 542.64M |
| September 16, 2026 | 532.85M |
| September 15, 2026 | 539.38M |
| September 14, 2026 | 548.52M |
| September 11, 2026 | 551.78M |
| September 10, 2026 | 568.76M |
| September 09, 2026 | 572.03M |
| September 08, 2026 | 592.92M |
| September 04, 2026 | 613.17M |
| September 03, 2026 | 607.94M |
| September 02, 2026 | 626.23M |
| September 01, 2026 | 605.98M |
| August 31, 2026 | 600.76M |
| Date | Value |
|---|---|
| August 28, 2026 | 599.45M |
| August 27, 2026 | 603.37M |
| August 26, 2026 | 608.60M |
| August 25, 2026 | 626.88M |
| August 24, 2026 | 609.90M |
| August 21, 2026 | 611.53M |
| August 20, 2026 | 589.33M |
| August 19, 2026 | 632.10M |
| August 18, 2026 | 604.68M |
| August 17, 2026 | 600.76M |
| August 14, 2026 | 585.74M |
| August 13, 2026 | 588.35M |
| August 12, 2026 | 579.21M |
| August 11, 2026 | 587.05M |
| August 10, 2026 | 587.05M |
| August 07, 2026 | 571.38M |
| August 06, 2026 | 566.80M |
| August 05, 2026 | 548.52M |
| August 04, 2026 | 587.70M |
| August 03, 2026 | 526.32M |
| July 31, 2026 | 517.94M |
| July 30, 2026 | 535.35M |
| July 29, 2026 | 530.19M |
| July 28, 2026 | 528.90M |
| July 27, 2026 | 530.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 15.31M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| Fulcrum Therapeutics, Inc. | 283.02M |
| Definium Therapeutics, Inc. | 4.868B |
| LeonaBio, Inc. | 52.57M |
Market Cap Related Metrics
| PE Ratio | 46.51 |
| PS Ratio | 1.577 |
| Price to Book Value | 0.8665 |
| Price | 7.46 |
| Earnings Yield | 2.15% |
| Normalized PE Ratio | 34.10 |